Adherence, sleep, and fatigue outcomes after adjuvant breast cancer chemotherapy: results of a feasibility intervention study.

Oncology nursing forum

Volumn 30, Issue 3, 2003, Pages 513-522

  Berger, Ann M ^a   VonEssen, Susanna ^a   Kuhn, Brett R ^a   Piper, Barbara F ^a   Agrawal, Sangeeta ^a   Lynch, James C ^a   Higginbotham, Patti ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; PACLITAXEL; TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; FATIGUE; FEASIBILITY STUDY; FEMALE; HUMAN; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDY; SLEEP DISORDER;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DOXORUBICIN; FATIGUE; FEASIBILITY STUDIES; FEMALE; HUMANS; MIDDLE AGED; PACLITAXEL; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; SLEEP DISORDERS; TAMOXIFEN;

EID: 0038777395     PISSN: None     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/03.ONF.513-522     Document Type: Article

References (0)